Discovery with discipline
We prioritize clear decision points over hype — candidates earn the next experiment.
Discovery · CNS program
Neurocreatine
Exploring peptides aimed at the mind and nervous system.
Neurocreatine is an early discovery track exploring CNS-oriented peptide concepts — using Florida Man Bioscience’s analytics posture to triage ideas and keep go/no-go decisions grounded in measurable signals.
Who it’s for. Scientific collaborators and partners interested in CNS peptide discovery.
Status: Early discovery track. Not a consumer or clinical product.
Why it matters
Marketing that stays honest.
Measurement-minded
Ideas are framed around signals you can track, so learning compounds as the program matures.
Tied to the platform
Neurocreatine sits inside the same FMB philosophy as our software loop: detect carefully, design deliberately, deliver only when ready.
What you can expect
Clear commitments. No theater.
- Early-stage discovery framing (no product claims)
- Aligned with genome-aware and biomarker thinking
- Open to thoughtful scientific collaboration
More from Florida Man Bioscience
Explore the portfolio.
Flagship
U4U
Flagship genome-aware platform — personalized peptide options from genetic context, for people and practitioners.
View page →Design lab
Next-gen drug design
Structure-guided design lab — immersive visualization and disciplined loops for peptide and protein work.
View page →Lab software
CytoGate
Flow analysis software for modern labs — clearer views of complex cell data, built for real workflows.
View page →Privacy toolkit
U4U Privacy
Local-first consumer genomics — tools that keep raw genetic data under your control.
View page →Delivery research
Vector nanodisk
Research-stage delivery science — a long-horizon path for peptide and nucleic-acid payloads.
View page →